Exhibit 99.1 Powerfleet Reports Robust Q3 Recurring Revenue Growth With11% Year-Over-Year Increase in Services Revenue Total revenue increased 7% year-over-year to a record $113.5 million from $106.4 million in Q3 FY25 Services revenue increased 11% to $91.1 million from $81.7 million in Q3FY25 Operating profit of $6.3 million, compared to an operating loss of $1.2 million in Q3 FY25 Net Loss improved to $3.4 million compared to $14.3 million in Q3 FY25 Adjusted EBITDA increased 26% to $25.7 million from $2 ...

"As we have entered 2026, we continue to progress our innovative clinical pipeline with particular focus on our lead candidate, oral blarcamesine in early Alzheimer's disease. Based on our commitment to improving the lives of patients with neurological disorders, we remain excited about the therapeutic potential of oral blarcamesine. We look forward to working with the regulatory agencies in Europe and the U.S. to advance oral blarcamesine as a potential new treatment option for patients." said Christopher ...

Exhibit 99.1 Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update WEST LAFAYETTE, IN, February 9, 2026 – Inotiv, Inc. (Nasdaq: NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months ("Q1 FY 2026") ended December 31, 2025. Revenue by Segment (in millions of USD) | | Three ...

Financial Performance - Kyndryl reported revenues of $3.9 billion for Q3 FY2026, a 3% increase year-over-year, with net income of $57 million, or $0.25 per diluted share[4]. - Adjusted pretax income was $168 million, reflecting an $8 million increase from the prior year, while adjusted net income was $122 million, or $0.52 per diluted share[5]. - Total revenue for the three months ended December 31, 2025, was $3,859 million, representing a 3% year-over-year growth[22]. - Net income for Q4 2025 was $57 million, a decrease from $215 million in Q4 2024, resulting in a net income margin of 1.5%[37]. - Adjusted EBITDA for Q4 2025 was $696 million, compared to $704 million in Q4 2024, with an adjusted EBITDA margin of 18.0%[37]. - Adjusted net income for the nine months ended December 31, 2025 was $301 million, compared to $159 million for the same period in 2024[37]. - Adjusted earnings per share (EPS) for Q4 2025 was $0.52, slightly up from $0.51 in Q4 2024[37]. Revenue Growth - Kyndryl Consult achieved a revenue growth of 24% year-over-year, with total revenues of $3.6 billion and signings of $4.1 billion over the last twelve months[8]. - The company generated $500 million in revenue from hyperscaler alliances, marking a 58% year-over-year increase, and is on track to exceed its fiscal 2026 target of $1.8 billion[8]. - Signings for the trailing twelve months reached $15.4 billion, with eleven customer contracts signed in Q3 exceeding $50 million each[7]. - Total signings for Q4 2025 were $3.9 billion, down from $4.1 billion in Q4 2024, with currency movements contributing five points to signings growth[40]. Cash Flow and Expenditures - Free cash flow for the quarter was $217 million, compared to $260 million in the prior-year period[5]. - Cash flows from operating activities for Q4 2025 were $427 million, compared to $260 million in Q4 2024[39]. - The company reported a net change in cash, cash equivalents, and restricted cash of $(437) million for the nine months ended December 31, 2025[24]. - The company experienced a decrease in net capital expenditures, which were $210 million in Q4 2025 compared to $93 million in Q4 2024[39]. - Capital expenditures for the nine months ended December 31, 2025, were $492 million, up from $365 million in 2024[24]. Share Repurchase and Debt - The company repurchased 3.7 million shares for $100 million in Q3, totaling 11 million shares repurchased for $349 million since the program's authorization[8]. - The company repurchased $250 million in common stock during the nine months ended December 31, 2025, compared to $30 million in the previous year[24]. - The total debt (short-term and long-term) was $3,100 million as of December 31, 2025[22]. Future Outlook - Kyndryl's fiscal year 2026 outlook includes adjusted pretax income of $575 to $600 million and free cash flow of $325 to $375 million[12]. - The projected pretax margin associated with recent signings is in the high-single-digit range, indicating strong profitability potential[8].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended December 31, 2025 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File No. 0-22818 THE HAIN CELESTIAL GROUP, INC. (Exact name of registrant as specified in its charter) (State or other juri ...

Financial Performance - Net sales for the fiscal second quarter were $384 million, a decrease of 7% year-over-year, with organic net sales also down 7%[4] - The gross profit margin was 19.4%, reflecting a 330-basis point decrease from the prior year period[4] - The net loss for the quarter was $116 million, compared to a net loss of $104 million in the prior year, including pre-tax non-cash impairment charges of $132 million[4] - Adjusted EBITDA was $24 million, down from $38 million in the prior year period, representing a decrease of 37%[4] - The company reported a net loss of $116.0 million in Q2 2026, compared to a net loss of $104.0 million in Q2 2025, reflecting an increase in losses of 10.1%[31] - Adjusted EBITDA for Q2 2026 was not explicitly stated but is calculated as net loss before various adjustments, indicating ongoing financial challenges[31] - The company reported a GAAP operating loss of $98,822 thousand in Q2 FY26, compared to a loss of $91,899 thousand in Q2 FY25[42] - The company reported a GAAP net loss of $116,006 in Q2 FY26, compared to a net loss of $103,975 in Q2 FY25, reflecting a year-over-year increase of 10.4%[45] - Adjusted net loss for Q2 FY26 was $(2,735), a significant decline from an adjusted net income of $7,506 in Q2 FY25, indicating a shift in financial performance[45] Sales Performance - North America segment organic net sales decreased by 10% year-over-year, primarily driven by declines in snacks and baby formula[8] - International segment organic net sales decreased by 3% year-over-year, showing sequential improvement from a 4% decrease in the previous quarter[11] - Organic net sales for Q2 2026 were $384.1 million, a decrease of 6.6% compared to $411.5 million in Q2 2025[31] - Q2 FY26 consolidated net sales decreased by 6.7% to $384,120 thousand compared to Q2 FY25, which was $411,485 thousand[37] - North America net sales in Q2 FY26 were $197,821 thousand, down 13.7% from $229,289 thousand in Q2 FY25[37] - The company experienced a net sales decline of 12.7% in North America for the year-to-date period compared to the previous year[47] - The impact of divestitures and discontinued brands accounted for a reduction of $22,932 in net sales for Q2 FY25, highlighting the effect of strategic business decisions[47] - The company reported a negative impact of $13.484 million from divestitures and exited product categories on net sales in Q2 FY26[49] - The impact of foreign currency exchange on net sales was $9.036 million in Q2 FY26[49] Cash Flow and Debt - Net cash provided by operating activities was $37 million, an increase from $31 million in the prior year period[12] - Free cash flow for the quarter was $30 million, compared to $25 million in the prior year[12] - Total debt remained stable at $705 million, with net debt decreasing to $637 million from $650 million at the beginning of the fiscal year[12] - Free cash flow for Q2 2026 was $36.97 million, an increase from $30.91 million in Q2 2025, showing improved cash generation from operations[35] - Net debt as of December 31, 2025, was $636.686 million, a decrease from $650.466 million as of June 30, 2025[55] Impairment and Goodwill - Goodwill impairment for Q2 2026 was $119.9 million, significantly higher than $91.3 million in Q2 2025, impacting overall financial performance[31] - The company incurred goodwill impairment charges of $119.908 million in Q2 FY26[51] Strategic Initiatives - The company is advancing its turnaround strategy, including the divestiture of its North American snack business to improve financial flexibility and margins[2] - The company continues to focus on organic net sales growth, excluding the impact of acquisitions and divestitures, to provide clearer insights into operational performance[29] - The company is focusing on productivity and transformation costs, which amounted to $5,234 thousand in Q2 FY26[42]

Financial Performance - Net revenues increased by 7% year-over-year to $13.39 million, up from $12.52 million[6] - Gross profit rose to $11.66 million, maintaining a stable gross profit margin of approximately 87%[6] - Net income before discontinued operations was $1.46 million, compared to a net loss of $(21.18) million in the prior year, marking the second consecutive quarter of profitability[6] - Adjusted EBITDA increased to $6.55 million from $4.26 million in the same period last year[6] - Total net revenues for the nine months ended December 31, 2025, were $37,236,005, a slight increase from $36,786,879 in the same period of 2024, representing a growth of approximately 1.2%[26] - Gross profit for the nine months ended December 31, 2025, was $32,439,767, compared to $31,901,007 for the same period in 2024, indicating an increase of about 1.7%[26] - Net income attributable to common stockholders for the nine months ended December 31, 2025, was $1,464,625, compared to a loss of $55,656,281 in the same period of 2024[26] - Basic income per share of common stock for the nine months ended December 31, 2025, was $0.01, compared to a loss of $0.34 in the same period of 2024[26] - The company reported a gross profit margin of approximately 86.9% for the nine months ended December 31, 2025, compared to 86.5% for the same period in 2024[26] Operating Expenses and Cash Flow - Operating expenses decreased by $21.76 million year-over-year, reflecting cost discipline and resolved legal disputes[6] - Operating expenses for the nine months ended December 31, 2025, totaled $35,777,635, a decrease from $64,672,926 in the same period of 2024, indicating a reduction of about 44.7%[26] - Generated over $4 million in cash from operations during the quarter, ending with $69.9 million in cash and cash equivalents[9] - Cash and cash equivalents increased significantly to $69,857,730 as of December 31, 2025, from $30,227,796 as of March 31, 2025, marking an increase of approximately 131.3%[24] Growth and Strategic Initiatives - The company is focused on sustainable growth through operational efficiency and digital innovation, with key priorities including increasing GMV and enhancing seller offerings[10] - Total gross merchandise value (GMV) increased by 6.4% to $215.8 million, with firearm sales up by 8% despite a 4% decline in adjusted NICS checks[7] - Continued enhancements to GunBroker.com included improved seller tools and user experience features[6][8] - The relocation of headquarters from Arizona to Georgia is part of ongoing corporate restructuring and operational streamlining initiatives[6] Balance Sheet and Assets - Total current assets increased to $82,518,544 as of December 31, 2025, from $72,148,138 as of March 31, 2025, reflecting a growth of approximately 14.5%[24] - Total liabilities decreased to $34,385,362 as of December 31, 2025, down from $75,303,066 as of March 31, 2025, a reduction of about 54.4%[24] - Total shareholders' equity increased to $237,267,909 as of December 31, 2025, from $222,026,563 as of March 31, 2025, representing a growth of approximately 6.8%[24]

Financial Performance - Net revenues increased by 7% year-over-year to $13.39 million, up from $12.52 million[6] - Gross profit rose to $11.66 million, maintaining a gross profit margin of approximately 87%[6] - Net income before discontinued operations was $1.46 million, compared to a net loss of $(21.18) million in the prior year, marking the second consecutive quarter of profitability[6] - Adjusted EBITDA increased to $6.55 million from $4.26 million in the same period last year[6] - Total net revenues for the nine months ended December 31, 2025, were $37,236,005, a slight increase from $36,786,879 in the same period of 2024, representing a growth of approximately 1.2%[26] - Gross profit for the nine months ended December 31, 2025, was $32,439,767, compared to $31,901,007 for the same period in 2024, indicating an increase of about 1.7%[26] - Net income attributable to common stockholders for the nine months ended December 31, 2025, was $1,464,625, compared to a loss of $55,656,281 in the same period of 2024[26] - Basic income per share of common stock for the nine months ended December 31, 2025, was $0.01, compared to a loss of $0.34 in the same period of 2024[26] - The company reported a gross profit margin of approximately 86.9% for the nine months ended December 31, 2025, compared to 86.5% for the same period in 2024[26] Operating Expenses and Cash Flow - Operating expenses decreased by $21.76 million year-over-year, reflecting cost discipline and resolved legal disputes[6] - Operating expenses for the nine months ended December 31, 2025, totaled $35,777,635, a decrease from $64,672,926 in the same period of 2024, indicating a reduction of about 44.8%[26] - Generated over $4 million in cash from operations during the quarter, ending with $69.9 million in cash and cash equivalents[9] - Cash and cash equivalents increased significantly to $69,857,730 as of December 31, 2025, from $30,227,796 as of March 31, 2025, marking an increase of approximately 131.3%[24] Growth and Market Performance - Total gross merchandise value (GMV) increased by 6.4% to $215.8 million, with firearm sales up by 8% despite a 4% decline in adjusted NICS checks[7] - The company is focused on sustainable growth through operational efficiency and digital innovation, with key priorities including increasing GMV and enhancing seller offerings[10] Corporate Restructuring - The relocation of headquarters from Arizona to Georgia is part of ongoing corporate restructuring and operational streamlining initiatives[6] - Total current assets increased to $82,518,544 as of December 31, 2025, from $72,148,138 as of March 31, 2025, reflecting a growth of approximately 14.5%[24] - Total liabilities decreased to $34,385,362 as of December 31, 2025, down from $75,303,066 as of March 31, 2025, a reduction of about 54.4%[24] - Total shareholders' equity increased to $237,267,909 as of December 31, 2025, from $222,026,563 as of March 31, 2025, representing a growth of approximately 6.8%[24] Product and Service Enhancements - Continued enhancements to GunBroker.com included improved seller tools and user experience features[6][8]

Financial Performance - Fourth quarter 2025 sales reached $932 million, a 7% increase from $873 million in Q4 2024[3] - Non-GAAP EPS for Q4 2025 grew 10% to $4.53, compared to $4.10 in Q4 2024[4] - Full-year 2025 sales totaled $3,165 million, reflecting a 7% increase from $2,958 million in 2024[10] - Recurring revenue increased 10% in Q4 2025, driven by strong demand in precision chemistries[9] - The pharmaceutical market saw an 8% sales increase in Q4 2025, while the industrial market also grew by 8%[8] - For the three months ended December 31, 2025, total net sales increased by 7% to $932,362 thousand compared to $872,714 thousand in the same period of 2024, with a constant currency growth rate of 6%[27] - For the twelve months ended December 31, 2025, total net sales reached $3,165,286 thousand, marking a 7% increase from $2,958,387 thousand in 2024, with a constant currency growth rate also at 7%[29] - Pharmaceutical market sales increased by 9% to $1,873,362 thousand, while the Industrial market grew by 6% to $961,154 thousand[29] - The total recurring revenue for the twelve months was $1,819,644 thousand, reflecting an 8% increase compared to the previous year[29] Future Projections - The company expects full-year 2026 organic constant currency revenue growth of 5.5% to 7.0%, translating to reported revenue of $3.355 billion to $3.405 billion[14] - Total company revenue for full-year 2026, including expected revenue synergies, is projected to be between $6.405 billion and $6.455 billion[15] - First quarter 2026 organic constant currency revenue growth is anticipated to be in the range of 7.0% to 9.0%[17] - The acquisition of BD Biosciences and Diagnostic Solutions is expected to contribute approximately $3.000 billion to reported revenue in 2026[14] - Non-GAAP EPS for full-year 2026 is projected to be between $14.30 and $14.50, representing year-over-year growth of approximately 8.9% to 10.4%[16] - Projected revenue for the twelve months ending December 31, 2026, is estimated to be between $6.405 billion and $6.455 billion, with organic reported revenue growth expected to be between 6.0% and 7.5%[41] - The company anticipates an impact of $3.0 billion from acquired business contributions to projected revenue for the twelve months ending December 31, 2026[41] - GAAP earnings per diluted share for the twelve months ending December 31, 2026, is projected to be between $6.63 and $6.83, while adjusted non-GAAP earnings per diluted share is expected to be between $14.30 and $14.50[41] Operational Highlights - Waters segment net sales rose by 8% to $823,937 thousand, while TA segment sales remained flat at $108,425 thousand[27] - Service revenue grew by 9% to $329,156 thousand, and Chemistry sales increased by 13% to $170,356 thousand, reflecting strong demand in these areas[27] - In terms of geography, Europe saw a significant increase of 13% in net sales, reaching $315,971 thousand, while Asia's sales grew by 4% to $283,967 thousand[27] - Asia's total net sales for the twelve months were $1,040,397 thousand, a 7% increase, with a constant currency growth rate of 13%[29] - The company emphasizes the importance of constant currency growth rates as a measure of underlying performance, excluding foreign currency impacts[27] - The overall performance indicates a solid growth trajectory across various segments and geographies, positioning the company favorably for future expansion[29] Financial Position - Total assets increased to $5,083,977 thousand as of December 31, 2025, up from $4,553,795 thousand in 2024[36] - Cash and cash equivalents rose to $587,831 thousand, compared to $325,355 thousand in the previous year[36] - Accounts receivable increased to $828,844 thousand, up from $733,365 thousand year-over-year[36] - Total liabilities decreased to $2,522,735 thousand from $2,725,288 thousand in 2024[36] - The company’s total stockholders' equity increased to $2,561,242 thousand as of December 31, 2025, compared to $1,828,507 thousand in 2024[36] Income and Cash Flow - The company reported a net income of $225,214 thousand for the three months ended December 31, 2025, with diluted earnings per share of $3.77[31] - Net income for the three months ended December 31, 2025, was $225.2 million, a decrease of 2.5% compared to $231.4 million for the same period in 2024[38] - Net cash provided by operating activities for the twelve months ended December 31, 2025, was $652.6 million, down 14.3% from $762.1 million in 2024[38] - Free Cash Flow - Adjusted Non-GAAP for the twelve months ended December 31, 2025, was $677.3 million, compared to $744.3 million in 2024, reflecting a decrease of 9%[38] - The company reported a net cash used in investing activities of $152.3 million for the twelve months ended December 31, 2025, compared to $144.0 million in 2024[38] - Stock-based compensation increased to $54.1 million for the twelve months ended December 31, 2025, from $44.7 million in 2024, representing a growth of 21.5%[38] - The company made business acquisitions totaling $35.1 million net of cash acquired during the twelve months ended December 31, 2025[38] - The effect of exchange rate changes on cash and cash equivalents resulted in an increase of $2.96 million for the three months ended December 31, 2025[38] Operating Income - For the three months ended December 31, 2025, GAAP operating income was $270,516 thousand, representing a 29.0% operating margin[31] - Adjusted non-GAAP operating income for the same period was $328,431 thousand, with a 35.2% operating margin[31] - The company incurred acquisition-related costs of $36,771 thousand, which accounted for 3.9% of total expenses in the three months ended December 31, 2025[31] - The adjusted non-GAAP net income for the twelve months ended December 31, 2025, was $929,890 thousand, with diluted earnings per share of $13.13[31]

Financial Performance - Q4 network volume reached $2.7 billion, growing 3% year-over-year and 34% excluding SFR, surpassing the outlook of $2.65 - $2.9 billion[3] - Total revenue and other income for Q4 was $335 million, a 20% year-over-year increase, exceeding the forecast of $333 - $358 million[4] - Adjusted EBITDA for Q4 was $98 million, reflecting a 53% year-over-year growth and an adjusted EBITDA margin increase of over 6 points to 29%[6] - GAAP net income for Q4 was $34 million, representing a 10% margin and a significant increase of $272 million year-over-year, driven by fee revenue growth[7] - The company achieved a record full-year revenue of $1.3 billion, growing 26% year-over-year, with adjusted EBITDA for the year at $371 million, up 76%[15] - Full year 2025 revenue reached $1,301 million, up 26% year-over-year, with adjusted EBITDA of $371 million, reflecting a 76% increase compared to 2024[52] - Total revenue for Q4 2025 reached $334.8 million, a 19.8% increase from $279.4 million in Q4 2024[101] - Net income attributable to Pagaya Technologies Ltd. was $34.3 million in Q4 2025, compared to a net loss of $237.9 million in Q4 2024[101] - Operating income for the year ended December 31, 2025, was $263.8 million, significantly up from $66.8 million in 2024[101] - Non-GAAP adjusted net income for the year was $275.3 million, compared to $66.9 million in 2024, reflecting a substantial increase[102] Funding and Investments - The company issued $2.9 billion in ABS across 7 transactions in Q4, enhancing funding capacity and diversifying funding sources[9] - The company diversified its funding structure, with about two-thirds of personal loan business funded by ABS in 2025, compared to almost entirely in 2024[41] - The company announced a $350 million revolving Personal Loans ABS transaction, providing up to approximately $3 billion of funding capacity[79] - Discretionary investments in loans and securities totaled approximately $171 million during 2025, enhancing liquidity and interest income[81] - The company is leveraging its capital structure to make opportunistic investments, with one-third of Investments in Loans and Securities being discretionary[81] Operational Efficiency - Approximately half of Q4 originations came from outside decline monetization, indicating a successful conversion of a core Personal Loan partner into a multi-product relationship[13] - The onboarding pipeline is the most robust in the company's history, with three new partners launched and multiple additional partners expected to go live in the coming quarters[36] - The company signed several long-term agreements with leading partners to enhance application flow size and quality, which is expected to unlock accelerated growth[40] - The company experienced a significant reduction in general and administrative expenses, decreasing from $240.8 million in 2024 to $159.6 million in 2025[101] - Core operating expenses as a percentage of FRLPC improved to 36% in 2025 from 56% in 2024, demonstrating enhanced operational efficiency[109] Future Outlook - For 2026, the company anticipates more measured volume and revenue growth, prioritizing credit risk over market share gains[27] - The company expects 2026 revenue to be between $11.25 billion and $13.0 billion, supported by new products and partner growth[58] - For Q1 2026, the company expects Network Volume between $2.5 billion and $2.7 billion, and Total Revenue & Other Income between $315 million and $335 million[87] - The full-year 2026 outlook includes Total Revenue & Other Income projected between $1.4 billion and $1.575 billion, with GAAP Net Income expected between $100 million and $150 million[87] - The FRLPC margin is expected to be between 4.0% and 5.0% for the year, reflecting potential credit-related impairments[86] Credit Performance - Credit performance remains stable, with cumulative net losses for personal loans trending approximately 30% - 40% lower than peak levels in Q4 2021[70] Shareholder Returns - The company repurchased approximately $7 million of its 8.875% senior unsecured notes at a discount of approximately 12.5% to par[82] - The weighted average shares outstanding for basic shares increased to 81.9 million in 2025 from 74.3 million in 2024[102]